Qing Lei

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions

Breast cancer remains the most frequently diagnosed malignancy and a leading cause of cancer-related mortality among women worldwide. While immune checkpoint inhibitors have transformed treatment for a subset of patients, durable responses remain limited, in part because the tumor immune microenvironment is profoundly...